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Abstract
Background: MALDI-TOF mass spectrometry (MS) is a reliable method for bacteria identification. Some databases used for
this purpose lack reference profiles for Brucella species, which is still an important pathogen in wide areas around the world.
We report the creation of profiles for MALDI-TOF Biotyper 2.0 database (Bruker Daltonics, Germany) and their usefulness for
identifying brucellae from culture plates and blood cultures.
Methodology/Principal Findings: We created MALDI Biotyper 2.0 profiles for type strains belonging to B. melitensis
biotypes 1, 2 and 3; B. abortus biotypes 1, 2, 5 and 9; B. suis, B. canis, B ceti and B. pinnipedialis. Then, 131 clinical isolates
grown on plate cultures were used in triplicate to check identification. Identification at genus level was always correct,
although in most cases the three replicates reported different identification at species level. Simulated blood cultures were
performed with type strains belonging to the main human pathogenic species (B. melitensis, B. abortus, B. suis and B. canis),
and studied by MALDI-TOF MS in triplicate. Identification at genus level was always correct.
Conclusions/Significance: MALDI-TOF MS is reliable for Brucella identification to the genus level from culture plates and
directly from blood culture bottles.
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Introduction
Brucellosis is a zoonosis that remains an important public health
problem in wide areas, such as the Mediterranean basin, the north
of Africa, Mexico, and Central and South America [1–4]. Six
species have been described, based on host preferences, metab-
olism, culture and antigenic features, including the two most
recent species (Brucella pinnipedialis and B. ceti), isolated from seals
and cetaceans (dolphins and whales), but most human cases
remain to be caused by B. melitensis and B. abortus [5]. However,
DNA-DNA hybridization shows a high homology between strains,
indicating that current species should be rather considered as
subspecies corresponding to evolutionary lineages adapted to
specific hosts [6].
Classically, biphasic blood cultures such as the Ruiz-Castan ˜eda
method were used to isolate brucellae from blood and bone
marrow. Now, most laboratories use continuous-monitoring
automated blood culture systems, which can shorten the time to
isolation and have been shown to be highly sensitive [7].
Nevertheless, subculture is necessary to identify the microorgan-
ism, and brucellae may require 2–3 days to grow on chocolate or
blood agar. Rapid automated bacterial identification systems must
be interpreted with caution, because brucellae have been
misidentified with some of these systems [8]. PCR have shown
high sensitivity and specificity, but its use remains infrequent,
mainly due to standardization problems [9].
MALDI-TOF mass spectrometry (MS) has been suggested as a
fast and reliable method for bacterial identification [10,11], based
on protein profiles characteristic of each microorganism. Data-
bases have been developed that include the main pathogenic
microorganisms, thus allowing the use of this method in routine
bacterial identification from plate culture. Nevertheless, Brucella
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available, because of problems derived from their potential
bioterrorist use. This is an important problem for the routine
use of MALDI-TOF MS for the direct diagnosis of blood cultures
in countries where brucellosis is still frequent.
The aim of our study was to identify and differentiate Brucella
species by MALDI-TOF MS, combining MALDI-TOF MS with
dedicated bioinformatics and statistical methods (database search
and pattern-matching algorithm). Initial spectra from three type
strains of B. melitensis, five type strains of B. abortus and one type
strain of B. suis, B. canis, B. ceti and B. pinnipedialis were used to set
up database entries for re-identification of Brucella strains. This
database was evaluated with 131 blind-coded Brucella clinical
isolates previously identified by conventional methods. We also
tested the reliability of this method for identifying brucellae
directly from blood cultures, as soon as artificially inoculated blood
cultures were reported as positive by a continuous-monitoring
automated blood culture system.
Materials and Methods
Ethic Statement
Sheep blood was used for some experiments, i.e. simulated
blood cultures. Since Sheep blood is obtained, as a conventional
laboratory product, from commercial sources (Pronadisa Conda,
Madrid, Spain), we did not consider any ethics approval to be
necessary for this study.
Microorganisms
The strains used for generating reference spectra were the
following: B. melitensis biotype 1, strain 16M (ATCC 23456); B.
melitensis biotype 2, strain 63/9 (ATCC 23457); B. melitensis biotype
3, strain ETHER (ATCC 23458); B. abortus biotype 1, strain 544
(ATCC 23448); B. abortus biotype 1, strain 45/20 (NCTC 11361);
B. abortus biotype 2, strain 86/8/59 (ATCC 23449); B. abortus
biotype 5, strain B3196 (ATCC 23452); B. abortus biotype 9, strain
C68 (ATCC 23455), B. suis (NCTC 10098), B. canis (NCTC
10854), B. ceti (NCTC 12891) and B. pinnipedialis (NCTC 12890)
Microorganisms were plated onto chocolate agar plates (bioMe ´r-
ieux, France), and incubated at 37uC for 48 hours. Colonies were
used for creating Biotyper 2.0 database profiles.
The same isolates were also spread onto blood agar plates
(bioMe ´rieux, France), under the same conditions, to check the
score reported by MALDI-TOF for colonies obtained from
different culture media.
One hundred and thirty one human clinical isolates were used
as blind coded isolates to check the reliability of the Biotyper 2.0
database, once spectra for B. melitensis, B. abortus, B. canis, B. ceti, B.
pinnipedialis and B. suis had been created. The clinical isolates were
plated onto chocolate agar plates (bioMe ´rieux, France), and
incubated at 37uC for 48 hours. Then, colonies were identified by
conventional microbiology methods and PCR, according previ-
ously described methods [12], and by MALDI-TOF MS.
Colonies samples preparation for MALDI-TOF MS
Cells of a whole colony were transferred from the plate to a
1.5 mL tube (Eppendorf, Germany) with a pipette tip and mixed
thoroughly in 300 mL of water to resuspend the bacterial cells.
Then, 900 mL of absolute ethanol was added and the mixture was
centrifuged at 15,500 g for 2 min and the supernatant was
discarded. The pellet was air-dried at room temperature for
1 hour. Subsequently, 50 mL of formic acid (70% v/v) were added
to the pellet and mixed thoroughly by pipetting before the addition
of 50 mL of acetonitrile to the mixture. The mixture was
centrifuged again at 15,500 g for 2 min. One microliter of the
supernatant was placed onto a spot of the steel target and air-dried
at room temperature. Each sample was overlaid with 1 mLo f
matrix solution (saturated solution of HCCA (alpha-cyano-4-
hydroxy cinnamic acid) in organic solvent (50% acetonitrile and
2.5% trifluoroacetic acid) and air-dried.
Simulated blood cultures. The same 3 B. melitensis,5B.
abortus,1B. canis and 1 B. suis type strains used for establishing
reference spectra, were used to perform simulated blood cultures.
Three to four colonies were suspended into sterile water to reach a
concentration around 10
4 CFU/mL. Then, 4 mL of brucellae
suspension were added to 4 mL of blood, and these 8 mL were
inoculated into BACTEC Plus + Aerobic/F bottles (Becton
Dickinson, NJ, USA), and incubated at 37uC in a BACTEC
9240 device (Becton Dickinson, NJ, USA), until they were
reported as positive.
Blood cultures samples preparation for MALDI-TOF MS
Four mL of the positive blood culture were centrifuged at
2,000 g for 30 seconds to remove leucocytes. Supernatant was
centrifuged at 15,500 g for 5 minutes to collect bacteria. The pellet
was washed once with de-ionized water. Then, the ethanol/formic
acid extraction procedure described above was applied.
MALDI-TOF MS
Measurements were performed on an Autoflex III MALDI-
TOF/TOF mass spectrometer (Bruker Daltonics, Leipzig, Ger-
many) equipped with a 200-Hz smartbeam laser. Spectra were
recorded in the linear positive mode at a laser frequency of 200 Hz
within a mass range from 2,000 to 20,000 Da. The IS1 voltage
was 20 kV, the IS2 voltage was maintained at 18.6 kV, the lens
voltage was 6 kV, and the extraction delay time was 40 ns.
For each spectrum, 500 laser shots were collected and analyzed
(10650 laser shots from different positions of the target spot). The
spectra were calibrated externally using the standard calibrant
mixture (Escherichia coli extracts including the additional proteins
RNase A and myoglobin, Bruker Daltonics). Calibration masses
were as follows: RL36, 4364.3 Da; RS22, 5095.8 Da; RL34,
5380.4 Da; RL33meth, 6254.4 Da, RL32, 6315 Da; RL29,
7273.5 Da; RS19, 10299.1 Da; RNase A, 13682.2 Da; myoglo-
bin, 16952.5 Da.
Spectrum generation and data analysis
For automated data analysis, raw spectra were processed using
the MALDI Biotyper 2.0 software (Bruker Daltonics, Leipzig,
Germany) at default settings. The software performs normaliza-
tion, smoothing, baseline subtraction, and peak picking, creating a
list of the most significant peaks of the spectrum (m/z values with a
given intensity, with the threshold set to a minimum of 1% of the
highest peak and a maximum of 100 peaks). To identify unknown
bacteria, each peak list generated was matched directly against
reference libraries (3,476 species) using the integrated patterns
matching algorithm of the Biotyper 2.0 software (Bruker Daltonics,
GmbH, Germany). The unknown spectra were compared with a
library of reference spectra based on a pattern recognition
algorithm using peak position, peak intensity distributions and
peak frequencies. Once a spectrum has been generated and
captured by the software, the whole identification process is
performed automatically, without any user intervention. MALDI-
TOF identifications were classified using modified score values
proposed by the manufacturer: a score $2 indicated species
identification; a score between 1.7 and 1.9 indicated genus
identification, and a score ,1.7 indicated no identification.
MALDI-TOF and Brucella
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recorded for each bacterial isolate (three independent measure-
ments at twelve different spots each).
Manual and visual estimation of the mass spectra was
performed using Flex Analysis 3.0 (Bruker Daltonics GmbH,
Germany) performing smoothing and baseline substraction.
Checking existence of flatlines, outliers or single spectra with
remarkable peaks differing from the other spectra was done, taking
into account that mass deviation within the spectra set should be
less than 500 ppm. Finally, 20 spectra were selected, removing
questionable spectra from the collection. To create peak lists of the
spectra, the BioTyper software was used as described above. The
70 independent peaks of a strain were used for automated ‘‘main
spectrum’’ generation with default settings of the BioTyper
software. Thereby, for each library entry a reference peak list
(main spectrum) which contains information about averaged
masses, averaged intensities, and relative abundances in the 20
measurements for all characteristic peaks of a given strain was
created, so a main spectrum displayed the most reproducible peaks
typical for a certain bacterial strain.
Cluster analysis was performed based on comparison of strain-
specific main spectra created as described above. The dendrogram
was constructed by the statistical toolbox of Matlab 7.1 (Math-
Works Inc., USA) integrated in the MALDI Biotyper 2.0 software.
The parameter settings were: ‘Distance Measure=Correlation’
and ‘Linkage=average’. The linkage function is normalized
according to the distance between 0 (perfect match) and 1000
(no match).
Results
MALDI Biotyper 2.0 database (Bruker Daltonics) used for
routine identification of microorganism in clinical microbiology
contains 3,476 entries, involving bacteria and fungi groups.
Although it contains a wide variety of clinically relevant
microorganisms, some important pathogenic microorganisms have
not been yet included (e.g. Brucella). This is an important limitation
in some countries, where brucellosis is still a relevant infectious
problem and it is not infrequent to isolate Brucella species from
febrile patients. For this reason, 3 B. melitensis,5B. abortus,1B. suis,
1 B. canis,1B. ceti and 1 B. pinnipedialis type strains were used to
generate reference spectra and to extend the MALDI Biotyper
database. The visual inspection of these spectra from whole-cell
extracts revealed a high similarity among them (Figure 1), with
specific peaks commons for all the strains at 2426 Da, 2585 Da,
3757 Da, 4851 Da, 5168 Da, 5870 Da, 6282 Da, 6672 Da,
7042 Da, 7393 Da, and 7511 Da (Table 1). Although some
differences can be observed among all the strains, only some
strains have discriminating peaks at species level. Thus, peaks at
4244, 4286 and 6854 Da appear only in B. melitensis, but none of
these peaks are constant in all the B. melitensis strains. The same
happens with peaks at 3899, 6166 and 7358 Da in B. abortus.
According these data, there is a peak profile characteristic of
Brucella at genus level, but there isn’t at species level.
A cluster analysis with the 12 type strains was performed, using
the integrated tools of the MALDI Biotyper 2.0 software package.
The resulting dendrogram (Figure 2) shows a close proximity
between B. ceti and B. pinnipedialis, and between B. suis and B. canis,
and more proximity between these four species than between any
of them and B. melitensis and B. abortus. Otherwise, B. melitensis and
B. abortus biotypes are extremely close and interrelated, excepting
B. abortus biotype 1 strain 544 (ATCC 23448).
In addition, we tested the influence of different culture
conditions. Therefore the different strains were cultivated on
blood agar and chocolate agar and comparison between
identification and scores obtained did not reveal any significant
difference between both culture media in any aspect (data not
shown).
Once established the spectra for the Brucella reference strains,
131 blind-coded Brucella strains were matched against the MALDI
Biotyper 2.0 database in triplicate, to prove its suitability for
routine identification and discrimination of Brucella at the genus
and species levels (Table 2). The MALDI-TOF device reported
the same identification at species level for the three replicates in 14
out of 17 B. abortus isolates (82.4%), but in only 12 out of 112 B.
melitensis isolates (10.7%) and in 1 out of 2 B. suis isolates (50%).
Therefore only 20.6% isolates reported the same identification at
species level for the three replicates. Nevertheless, in all of them
this identification was coincident with conventional and genetic
identifications at genus level. In all the clinical isolates tested, the
score difference between the ten most probably matched species
reported by the MALDI Biotyper software for each isolate was
very low and higher than 2 in several of them. As an example, we
show in Table 3 the score difference between the ten most
probably matched species reported for one B. melitensis clinical
isolate. Taking into account that a reliable identification at species
level is accepted with scores higher than 2, we can’t discriminate
between different Brucella species, since different Brucella species
give scores higher than 2 in most clinical isolates.
To test the reliability of MALDI-TOF MS for identifying
brucellae directly from blood culture, we inoculated blood culture
bottles with type strains belonging to the four main human
pathogenic species (B. melitensis, B. abortus, B. suis and B. canis). All
the blood cultures inoculated were reported as positive by
48 hours of incubation. Three replicates of each positive blood
culture were studied using MALDI-TOF MS. All the blood
cultures were reported by the MALDI-TOF as Brucella. Never-
theless, in several cases the identification did not match with the
organism inoculated in the blood culture at the species level, or
different identifications were obtained at the species level among
the three replicates of the same blood culture (Table 4).
Discussion
Brucellosis remains a serious problem in wide areas around the
world. Symptoms are nonspecific (fever, malaise, back pain, profuse
night sweating). This lack of specificity of symptoms may delay the
diagnosis for weeks. Though mortality rate is currently low, it
remains a severe disease, and complications such as epididymo-
orchitis, arthritis (especially sacroiliitis), and CNS complications are
not infrequent. The current taxonomy of this genus is confusing
because traditional, phenotype-based classification, and genetic-
based classification are used simultaneously [5]. Genetic taxonomic
studies have suggested that the 8 currently accepted species,
including the 2 marine mammal-associated species, represent a
single species [6,13]. Nevertheless, recent studies show that
traditional species, and the marine mammals-associated species,
can be differentiated by outer membrane genes polymorphism,
insertion sequences and whole-chromosome preparations [5,14].
Human brucellosis has been described associated to B. melitensis,
B. abortus, B. suis and B. canis, among the traditional species.
Human cases associated to the newer marine mammals-associated
species have also been reported [15,16]. Though B. abortus has the
broadest geographical distribution, most human cases are now
caused by B. melitensis, which usually produces the most severe
disease.
Microbiological procedures for Brucella detection and identifica-
tion have been controversial for years. Blood, and eventually bone
MALDI-TOF and Brucella
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brucellosis. Conventional blood cultures did not yield satisfactory
results, and this led to the development of the classic biphasic blood
cultures technique proposed by Ruiz-Castan ˜eda. Now, both lyses-
centrifugation methods and continuous monitoring blood cultures
devices are able to detect Brucella with a good sensitivity [7].
Early suspicion that an isolate might be a Brucella is important,
both for clinical and epidemiological reasons, because of the
hazard of laboratory-acquired brucellosis, and for the early
detection of a hypothetical bioterrorist attack. Early suspicion
may be currently established based on Gram staining, but final
identification requires colonies growth on agar plates and
performing biochemical or serological tests on these colonies.
For all those reasons, the availability of methods that allow a
rapid and reliable Brucella identification both from agar plates and
directly from the blood culture bottles, once this is reported as
positive by the continuous-monitoring blood culture systems,
would be extremely useful. Direct detection methods based on
PCR have been described [17], but these methods are expensive,
can be affected by PCR inhibitors present in blood, and do not
give any information about the viability of the microorganisms.
Thus, they have not reached a wide diffusion by now.
MALDI-TOF MS is an important and increasingly available
tool in clinical microbiology laboratories, because it allows a rapid
and accurate identification of bacteria [10,11]. We have seen that
MALDI-TOF MS allows a fast and highly reliable identification of
Brucella, at genus level, from colonies growth. Nevertheless,
identification at species level is less reliable. Data in Figure 1
and Table 1 show a common profile for all Brucella type strains
tested, but no specific peaks are found in any species. This explains
the reliability at genus level and the low reliability at species level.
Otherwise, the high similarity between all type strains is not
surprising, since genetic taxonomic studies suggest that the 6
currently accepted species represent a single species [6,13]. Once
Table 1. Discriminating peaks of Brucella strains and biotypes analyzed by MALDI-TOF MS.
peaks (m/z)
2426 2585 2671 2827 3337 3680 3757 3899 4068 4159 4244 4286 4338 4410 4504 4538 4851
B. mellitensis bt. 1, strain 16M (ATCC 23456) x x x x x x xxxx
B. mellitensis bt. 2, strain 63/9 (ATCC 23457) xxxxx x xx x xxxx
B. mellitensis bt. 3, strain ETHER (ATCC 23458) xxxxx x x xxx
B. abortus bt. 1, strain 544 (ATCC 23448) xxxxx xxx xxxx
B. abortus bt. 2, strain 86/8/59 (ATCC 23449) xxxxx xxx xxxx
B. abortus bt. 5, strain B 3196 (ATCC 23452) x x x x xxxx
B. abortus bt. 9, strain C68 (ATCC 23455) x x x x x x
B. abortus bt.1, strain 45/20 (NCTC 11361) x x x x x x x xxxx
B. suis (NCTC 10098) x x x x x x x x
B. canis ( N C T C 1 0 8 5 4 ) xx x x x xxxxx
B. ceti (NCTC 12891) x x x x x x x
B. pinnipedialis (NCTC 12890) x x x x x x x x
peaks (m/z)
5168 5870 5918 6042 6166 6282 6672 6854 7042 7327 7358 7393 7511 8675 9074 9103 9787
B. mellitensis bt. 1, strain 16M (ATCC 23456) x x x x x x x x x x
B. mellitensis bt. 2, strain 63/9 (ATCC 23457) x x x x x x x x x x
B. mellitensis bt. 3, strain ETHER (ATCC 23458) x x x x x x x x x x
B. abortus bt. 1, strain 544 (ATCC 23448) xxxx xx x xx x x
B. abortus bt. 2, strain 86/8/59 (ATCC 23449) xxxx xx x xx x x
B. abortus bt. 5, strain B 3196 (ATCC 23452) xxxxxxx x xx x x
B. abortus bt. 9, strain C68 (ATCC 23455) xxxxxxx x xx x x
B. abortus bt.1, strain 45/20 (NCTC 11361) x x x x x x x x x x x
B. suis (NCTC 10098) x x x x x x x x x x
B. canis ( N C T C 1 0 8 5 4 ) xxxx xx x xxxx x
B. ceti (NCTC 12891) x x x x x x x x x x
B. pinnipedialis (NCTC 12890) x x x x x x x x x
The m/z value stands for mass to charge ratio. For a single positive charge, this value corresponds to the molecular weight of the protein. The mass tolerance is
considered 62 Da for each peak.
doi:10.1371/journal.pone.0014235.t001
Figure 1. MALDI-TOF MS spectra of whole-cell extracts of Brucella reference strains in the range from 2000 to 11000 Da. The relative
intensity of the ions (a.u., arbitrary units) are shown on the y axis, and the masses (in Da) of the ions are shown on the x axis. The m/z value stands for
mass to charge ratio. For a single positive charge, this value corresponds to the molecular weight of the protein.
doi:10.1371/journal.pone.0014235.g001
MALDI-TOF and Brucella
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and B. pinnipedialis had been created and included in the database,
all the blind-coded Brucella isolates tested were correctly identified,
with scores .2. Scores differences between the 10 most probably
matched species given by the MALDI Biotyper software for each
isolate were extremely low, and replicates of the same protein
extract were sometimes identified as different species. In almost all
isolates, more than one species matched with score value .2 in the
10 most probably matched species, thus confirming the low
discriminating power at species level. The agar on which the
microorganism grows does not seem to affect to identification,
since scores obtained from blood agar and chocolate agar were
similar for all the isolates tested. Previous studies on other
microorganisms agree with these results, showing that MALDI-
TOF MS protein fingerprints are not significantly influenced by
variability in growth conditions [18–20].
Figure 2. Cluster analysis of MALDI-TOF MS spectra of Brucella strains and biotypes. Distance is displayed in relative units.
doi:10.1371/journal.pone.0014235.g002
Table 2. Identification by MALDI-TOF mass spectrometry and conventional identification of 131 blind-coded Brucella.
Conventional Identification (nu isolates) MALDI-TOF Identification
Correlation at the genus
level (%) Correlation at the species level (%)
3/3
* 2/3
* 1/3
* 0/3
*
B. abortus (17) 100 82.4 11.8 0 5.9
B. melitensis (112) 100 10.7 8.9 23.2 57.1
B. suis (2) 100 50 0 0 50
Total (131) 100 20.6 9.2 19.8 50.4
Each strain was spotted three times (replicates 1, 2 and 3).
N No. of replicates.
doi:10.1371/journal.pone.0014235.t002
MALDI-TOF and Brucella
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identify microorganisms directly from blood cultures reported as
positive by automatic blood culture processing devices [21–25]. In
our study, positive blood cultures spiked with brucellae were
reported always as Brucella, but species failures were frequent, as
had been shown previously in agar plates. Brucella was always
identified with scores .2 but, as happens in agar cultures, score
differences between the ten most probably matched species
reported by the MALDI Biotyper software for each isolate were
very low, and species identification had scores .2 in the best and
second match, although the species in both cases are different,
indicating that the species identification cannot be fully reliable.
Protein profiles found for type strains, show that protein profile
similarity does not correlate always with the traditional genus/
Table 3. Ten best matches for each replicate of a blind-coded clinical isolate.
Replicate 1 Replicate 2 Replicate 3
Matched Pattern Score Matched Pattern Score Matched Pattern Score
Value Value Value
1 Brucella melitensis bt 1, strain 16M
(ATCC 23456)
2.293 Brucella abortus bt 9, strain C68
(ATCC 23455)
2.229 Brucella melitensis bt 1, strain 16M
(ATCC 23456)
2.204
2 Brucella abortus bt 2, strain 86/8/59
(ATCC 23449)
2.161 Brucella melitensis bt 1, strain 16M
(ATCC 23456)
2.204 Brucella melitensis bt 2, strain 63/9
(ATCC 23457)
2.11
3 Brucella abortus bt 1, strain 544
(ATCC 23448)
2.158 Brucella abortus bt 5, strain B3196
(ATCC 23452)
2.204 Brucella abortus bt 2, strain 86/8/59
(ATCC 23449)
2.092
4 Brucella abortus bt 9, strain C68
(ATCC 23455)
2.148 Brucella abortus bt 1, strain 544
(ATCC 23448)
2.166 Brucella abortus bt 1, strain 544
(ATCC 23448)
2.087
5 Brucella abortus bt 5, strain B3196
(ATCC 23452)
2.138 Brucella abortus bt 2, strain 86/8/59
(ATCC 23449)
2.083 Brucella abortus bt 5, strain B3196
(ATCC 23452)
2.064
6 Brucella abortus 45/20 (NCTC 11361) 2.125 Brucella melitensis bt 2, strain 63/9
(ATCC 23457)
2.043 Brucella abortus 45/20 (NCTC 11361) 2.034
7 Brucella melitensis bt 2, strain 63/9
(ATCC 23457)
2.124 Brucella abortus 45/20 (NCTC 11361) 1.985 Brucella abortus bt 9, strain C68
(ATCC 23455)
2.006
8 Brucella canis (NCTC 10854) 2.062 Brucella suis (NCTC 10098) 1.908 Brucella suis (NCTC 10098) 1.898
9 Brucella suis (NCTC 10098) 2.056 Brucella canis (NCTC 10854) 1.902 Brucella canis (NCTC 10854) 1.867
10 Brucella melitensis bt 3, strain ETHER
(ATCC 23458)
1.919 Brucella ceti (NCTC 12891) 1.847 Brucella melitensis bt 3, strain ETHER
(ATCC 23458)
1.743
This isolate was identified as B. melitensis by conventional and genetic methods.
doi:10.1371/journal.pone.0014235.t003
Table 4. MALDI Biotyper 2.0-based identification of blood cultures spiked with different Brucella species and biotypes.
Organism reported by MALDI-TOF (best match)
Strains inoculated in blood cultures Replicate 1
Score
value Replicate 2
Score
value Replicate 3
Score
value
B. abortus bt. 1, strain 45/20 (NCTC 11361) B. melitensis bt. 1, strain 16M
(ATCC 23456)
2.09 B. abortus 45/20 1994 IX 2.16 B. abortus 45/20 1994 IX 2.125
B.abortus bt. 5, strain B3196 (ATCC 23452) B. canis (NCTC 10854) 2.319 B. abortus bt. 1, strain 544
(ATCC 23448)
2.376 B. abortus bt. 1, strain 544
(ATCC 23448)
2.256
B. abortus bt. 2, strain 86/8/59 (ATCC 23449) B. abortus bt. 1, strain 544
(ATCC 23448)
2.329 B. canis (NCTC 10854) 2.068 B. abortus bt. 9, strain C68
(ATCC 23455)
2.216
B. abortus bt. 9, strain C68 (ATCC 23455) B. abortus bt. 1, strain 544
(ATCC 23448)
2.268 B. abortus bt. 1, strain 544
(ATCC 23448)
2.321 B. canis (NCTC 10854) 2.252
B. melitensis bt. 1, strain 16M (ATCC 23456) B. melitensis bt. 1, strain 16M
(ATCC 23456)
2.219 B. melitensis bt. 1, strain 16M
(ATCC 23456)
2.224 B. melitensis bt. 1, strain
16M (ATCC 23456)
2.213
B. melitensis bt. 2, strain 63/9 (ATCC 23457) B. melitensis bt. 1, strain 16M
(ATCC 23456)
2.121 B. abortus bt. 1, strain 544
(ATCC 23448)
2.216 B. canis (NCTC 10854) 2.224
B. abortus bt. 1, strain 544 (ATCC 23448) B. abortus bt. 1, strain 544
(ATCC 23448)
2.388 B. abortus bt. 1, strain 544
(ATCC 23448)
2.257 B. abortus bt. 1, strain
544 (ATCC 23448)
2.355
B. melitensis bt. 3, strain ETHER
(ATCC 23458)
B. canis (NCTC 10854) 1.888 B. melitensis bt 3, strain
ETHER (ATCC 23458)
1.943 B. canis (NCTC 10854) 1.995
B. suis (NCTC 10098) B. suis (NCTC 10098) 2.465 B. suis (NCTC 10098) 2.429 B. suis (NCTC 10098) 2.481
B. canis (NCTC 10854) B. canis (NCTC 10854) 1.929 B. canis (NCTC 10854) 2.007 B. canis (NCTC 10854) 1.983
doi:10.1371/journal.pone.0014235.t004
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biotypes may be closer to other species than to other biotypes
belonging to the same species, as can be observed in cluster
analysis (Figure 2).
In summary, the protein profiles for type strains of B. melitensis
biotypes 1, 2 and 3; B. abortus biotypes 1, 2, 5 and 9; B. suis; B. canis;
B. ceti and B. pinnipedialis were generated and included in the
MALDI Biotyper database. The study of clinical isolates both from
agar plate cultures and directly from blood cultures showed that
these profiles allow a reliable identification of brucellae to genus
level, stating that MALDI-TOF MS is an fast and highly reliable
technique for straightforward Brucella identification, both from
culture plates and directly from blood culture vials.
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